The Valley Desk

Clinical trial reportEuropean neuropsychopharmacology : the journal of the European College of NeuropsychopharmacologyPublished

Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published
Subject terms
Humans; Urea; Pyridazines; Pyridines; Amidohydrolases; Antidepressive Agents; Enzyme Inhibitors; Treatment Outcome; Drug Therapy, Combination; Double-Blind Method; Anxiety; Adolescent
PubMed ID
41616640
Added to directory
Source checked

Report a correction or request removal